Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

Neola Medical to present at Redeye Technology & Life Science Day

Neola Medical

Neola Medical AB will present live at the Redeye Technology and Life Science Day in Stockholm hosted by Redeye on December 3, 2024 at 13:40 CET. Tune in to watch CEO Hanna Sjöström share Neola Medical’s latest progress toward transforming neonatal care, followed by a live Q&A session offering deeper insights into the company’s strategy, clinical advancements, and vision for the future at: https://www.redeye.se/events/1038747/redeye-technology-life-science-day

"I’m delighted to share Neola Medical’s recent advancements with investors and stakeholders. This event offers a unique opportunity to highlight our progress toward transforming neonatal care, including key steps on the path to U.S. market approval. I look forward to a dynamic Q&A session to discuss our clinical development, strategic goals, and the value we aim to create for patients, healthcare providers, and our shareholders.” says CEO Hanna Sjöström

The presentation will also be accessible for viewing afterward on www.redeye.se and our company website at www.neolamedical.com

For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Attachments
Neola Medical to present at Redeye Technology & Life Science Day

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team